IT1217458B - Sulfoamino derivati di condroitin solfati,del dermatan solfato e dell' acido ialuronico e loro proprieta' farmacologiche - Google Patents

Sulfoamino derivati di condroitin solfati,del dermatan solfato e dell' acido ialuronico e loro proprieta' farmacologiche

Info

Publication number
IT1217458B
IT1217458B IT20412/88A IT2041288A IT1217458B IT 1217458 B IT1217458 B IT 1217458B IT 20412/88 A IT20412/88 A IT 20412/88A IT 2041288 A IT2041288 A IT 2041288A IT 1217458 B IT1217458 B IT 1217458B
Authority
IT
Italy
Prior art keywords
derivatives
hyaluronic acid
heparin
sulfoamino
activity
Prior art date
Application number
IT20412/88A
Other languages
English (en)
Other versions
IT8820412A0 (it
Inventor
Benito Casu
Giangiacomo Torri
Annamaria Naggi
Marisa Mantovani
Rodolfo Pescador
Roberto Porta
Giuseppe Prino
Original Assignee
Crinos Ind Farmacoriologica S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crinos Ind Farmacoriologica S filed Critical Crinos Ind Farmacoriologica S
Publication of IT8820412A0 publication Critical patent/IT8820412A0/it
Priority to IT20412/88A priority Critical patent/IT1217458B/it
Priority to AT89107615T priority patent/ATE109163T1/de
Priority to EP89107615A priority patent/EP0340628B1/en
Priority to ES89107615T priority patent/ES2057006T3/es
Priority to DE68917009T priority patent/DE68917009T2/de
Priority to PT90414A priority patent/PT90414B/pt
Priority to AU33922/89A priority patent/AU618346B2/en
Priority to JP1112324A priority patent/JPH01318002A/ja
Priority to KR1019890005904A priority patent/KR900018129A/ko
Priority to US07/346,502 priority patent/US5008253A/en
Priority to CA000598507A priority patent/CA1307525C/en
Application granted granted Critical
Publication of IT1217458B publication Critical patent/IT1217458B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06—Aminosugars
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
IT20412/88A 1988-05-02 1988-05-02 Sulfoamino derivati di condroitin solfati,del dermatan solfato e dell' acido ialuronico e loro proprieta' farmacologiche IT1217458B (it)

Priority Applications (11)

Application Number Priority Date Filing Date Title
IT20412/88A IT1217458B (it) 1988-05-02 1988-05-02 Sulfoamino derivati di condroitin solfati,del dermatan solfato e dell' acido ialuronico e loro proprieta' farmacologiche
DE68917009T DE68917009T2 (de) 1988-05-02 1989-04-27 Sulfaminoderivate von Chondroitinsulfat, Dermatansulfat und Hyaluronsäure und ihre pharmakologischen Eigenschaften.
EP89107615A EP0340628B1 (en) 1988-05-02 1989-04-27 Sulfoamino derivatives of chondroitin sulfates, of dermaten sulfate and of hyaluronic acid and their pharmacological properties
ES89107615T ES2057006T3 (es) 1988-05-02 1989-04-27 Derivados sulfoamino de sulfatos de controitina, de sulfato de dermatano y de acido hialuronico y sus propiedades farmacologicas.
AT89107615T ATE109163T1 (de) 1988-05-02 1989-04-27 Sulfaminoderivate von chondroitinsulfat, dermatansulfat und hyaluronsäure und ihre pharmakologischen eigenschaften.
PT90414A PT90414B (pt) 1988-05-02 1989-04-28 Processo para a preparacao de derivados sulfaminados sinteticos de glicosaminoglicanos, nomeadamente, sulfatos de controitina, sulfato de dermatano e acido hialuronico e/ou suas misturas e de composicoes farmaceuticas que os contem
AU33922/89A AU618346B2 (en) 1988-05-02 1989-05-02 Sulfoamino derivatives of chondroitin sulfates, of dermatan sulfate and of hyaluronic acid and their pharmacological properties
JP1112324A JPH01318002A (ja) 1988-05-02 1989-05-02 コンドロイチン硫酸塩の、デルマタン硫酸塩の、およびヒアルロン酸のスルホアミノ誘導体類、並びにそれらの薬学的性質
KR1019890005904A KR900018129A (ko) 1988-05-02 1989-05-02 콘드로이틴 황산염, 데르마탄황산염 및 히알루론산의 술포아미노 유도체와 그 약제학적 성질
US07/346,502 US5008253A (en) 1988-05-02 1989-05-02 Sulfoamino derivatives of chondroitin sulfates of dermatan sulfate and of hyaluronic acid and their pharmacological properties
CA000598507A CA1307525C (en) 1988-05-02 1989-05-02 Sulfoamino derivatives of chondroitin sulfates, of dermatan sulfate and hyaluronic acid and their pharmacological properties

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20412/88A IT1217458B (it) 1988-05-02 1988-05-02 Sulfoamino derivati di condroitin solfati,del dermatan solfato e dell' acido ialuronico e loro proprieta' farmacologiche

Publications (2)

Publication Number Publication Date
IT8820412A0 IT8820412A0 (it) 1988-05-02
IT1217458B true IT1217458B (it) 1990-03-22

Family

ID=11166540

Family Applications (1)

Application Number Title Priority Date Filing Date
IT20412/88A IT1217458B (it) 1988-05-02 1988-05-02 Sulfoamino derivati di condroitin solfati,del dermatan solfato e dell' acido ialuronico e loro proprieta' farmacologiche

Country Status (11)

Country Link
US (1) US5008253A (it)
EP (1) EP0340628B1 (it)
JP (1) JPH01318002A (it)
KR (1) KR900018129A (it)
AT (1) ATE109163T1 (it)
AU (1) AU618346B2 (it)
CA (1) CA1307525C (it)
DE (1) DE68917009T2 (it)
ES (1) ES2057006T3 (it)
IT (1) IT1217458B (it)
PT (1) PT90414B (it)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8826448D0 (en) * 1988-11-11 1988-12-14 Thrombosis Res Inst Improvements in/relating to organic compounds
DE69005251T2 (de) * 1989-10-04 1994-05-05 Akzo Nv Sulfatierte Glykosaminoglykuronane mit antithrombotischer Wirkung.
FR2655267B1 (fr) * 1989-12-04 1992-04-03 Roussel Uclaf Nouveau derive sulfate du galactanne extrait de klebsiella, procede de preparation, application a titre de medicaments et compositions pharmaceutiques le renfermant.
WO1991015217A1 (en) * 1990-04-06 1991-10-17 Washington University Anticoagulant oligosaccharides
FR2669932B1 (fr) * 1990-12-03 1994-07-01 Sanofi Sa Nouvel heparosane-n,o-sulfate, son procede de preparation et les compositions pharmaceutiques qui le contiennent.
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
GB2286193A (en) * 1991-03-28 1995-08-09 Italfarmaco Spa Anticoagulants and processes for preparing such
US5705178A (en) * 1991-05-31 1998-01-06 Gliatech, Inc. Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
US5605938A (en) * 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
US5234914A (en) * 1991-06-11 1993-08-10 Patent Biopharmaceutics, Inc. Methods of treating hemorrhoids and anorecial disease
DE69411709D1 (de) * 1993-01-21 1998-08-20 Mayo Foundation Mikropartikelschaltvorrichtung
US5654006A (en) * 1993-02-12 1997-08-05 Mayo Foundation For Medical Education And Research Condensed-phase microparticle composition and method
US5820879A (en) * 1993-02-12 1998-10-13 Access Pharmaceuticals, Inc. Method of delivering a lipid-coated condensed-phase microparticle composition
US5753261A (en) * 1993-02-12 1998-05-19 Access Pharmaceuticals, Inc. Lipid-coated condensed-phase microparticle composition
ITPD940054A1 (it) * 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
US5690961A (en) * 1994-12-22 1997-11-25 Hercules Incorporated Acidic polysaccharides crosslinked with polycarboxylic acids and their uses
IT1290814B1 (it) * 1997-03-24 1998-12-11 Istituto Scient Di Chimica E B Glicosaminoglicani aventi elevata attivita' antitrombotica
ATE229038T1 (de) * 1997-04-04 2002-12-15 Fidia Advanced Biopolymers Srl N-sulfatierte hyaluronsäureverbindungen, ihre derivate und verfahren zu ihrer herstellung
DE19813234A1 (de) * 1998-03-26 1999-09-30 Knoell Hans Forschung Ev Verfahren zur Herstellung hochsulfatierter Hyaluronsäuren
US20060188966A1 (en) * 1998-04-02 2006-08-24 Deangelis Paul L Natural, chimeric and hybrid glycosaminoglycan polymers and methods of making and using same
US20030104601A1 (en) * 1999-04-01 2003-06-05 Deangelis Paul L. Chondroitin synthase gene and methods of making and using same
US20080108110A1 (en) * 1998-04-02 2008-05-08 Deangelis Paul L Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same
US7223571B2 (en) * 1998-04-02 2007-05-29 The Board Of Regents Of The Universtiy Of Oklahoma Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same
CA2330388A1 (en) 1998-04-30 1999-11-11 Maruha Corporation Compounds having glucuronic acid derivative and glucosamine derivative in structure thereof, method for producing the compounds, and uses of the compounds
ITPD980169A1 (it) 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
US7642071B2 (en) 1999-04-01 2010-01-05 The Board Of Regents Of The University Of Oklahoma Methods of expressing gram-negative glycosaminoglycan synthase genes in gram-positive hosts
EP1292314A2 (en) * 2000-05-23 2003-03-19 The Trustees of Columbia University in the City of New York Method for treating respiratory disorders associated with pulmonary elastic fiber injury comprising the use of glycosaminoglycans
US20040161476A1 (en) * 2003-02-19 2004-08-19 Hahn Sungtack Samuel Cystitis treatment with high dose chondroitin sulfate
ITPD20050056A1 (it) 2005-03-02 2006-09-03 Fidia Farmaceutici Derivati ammidici del'acido ialuronico in osteoartrosi
AU2009231634B2 (en) 2008-04-04 2014-05-15 University Of Utah Research Foundation Alkylated semi-synthetic glycosaminoglycosan ethers, and methods for making and using thereof
IT1397247B1 (it) * 2009-05-14 2013-01-04 Fidia Farmaceutici Nuovi agenti regolatori dell'attivita' citochinica
US8546353B2 (en) * 2010-05-06 2013-10-01 Glykos Finland Oy Compounds and combinations
CA2830933A1 (en) 2011-03-23 2012-09-27 University Of Utah Research Foundation Methods for treating or preventing urological inflammation
CA2932532C (en) 2012-12-04 2021-06-22 Phosphorex, Inc. Microparticles and nanoparticles having negative surface charges
WO2016159296A1 (ja) * 2015-03-31 2016-10-06 生化学工業株式会社 グリコサミノグリカンの硫酸化方法
US11337994B2 (en) 2016-09-15 2022-05-24 University Of Utah Research Foundation In situ gelling compositions for the treatment or prevention of inflammation and tissue damage
CN111662394B (zh) * 2019-03-05 2022-11-04 中国医学科学院药物研究所 硫酸软骨素多糖半合成制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB838709A (en) * 1955-09-22 1960-06-22 Upjohn Co Improvements in or relating to aminoalcohol-n-sulphonic acid compounds
US3405120A (en) * 1966-01-27 1968-10-08 Green Cross Corp Low molecular chondroitin sulfate and method for manufacturing the same
FR2504535B1 (fr) * 1981-04-28 1987-08-14 Choay Sa Disaccharides derives d'un acide uronique et d'une glucosamine et compositions pharmaceutiques les contenant pour le controle de la coagulation sanguine
US4818816A (en) * 1981-04-28 1989-04-04 Choay, S.A. Process for the organic synthesis of oligosaccharides and derivatives thereof
EP0838709A3 (de) * 1996-09-30 1999-07-28 Siemens Aktiengesellschaft Anordnung zur Erzeugung einer Umsetzung zwischen Lichtstrahlen kleineren Strahlquerschnitts und einem Lichtstrahl grösseren Strahlquerschnitts

Also Published As

Publication number Publication date
EP0340628B1 (en) 1994-07-27
IT8820412A0 (it) 1988-05-02
EP0340628A3 (en) 1990-01-24
AU618346B2 (en) 1991-12-19
US5008253A (en) 1991-04-16
ATE109163T1 (de) 1994-08-15
KR900018129A (ko) 1990-12-20
DE68917009T2 (de) 1994-11-10
PT90414B (pt) 1994-08-31
JPH01318002A (ja) 1989-12-22
AU3392289A (en) 1989-11-02
PT90414A (pt) 1989-11-30
DE68917009D1 (de) 1994-09-01
EP0340628A2 (en) 1989-11-08
ES2057006T3 (es) 1994-10-16
CA1307525C (en) 1992-09-15

Similar Documents

Publication Publication Date Title
IT1217458B (it) Sulfoamino derivati di condroitin solfati,del dermatan solfato e dell' acido ialuronico e loro proprieta' farmacologiche
IT1260137B (it) Glicosaminoglicani semisintetici a struttura eparinica od eparanica modificati nella posizione 2 dell'acido alfa-l-iduronico-2-0-solfato
ES2043786T3 (es) Un proceso para la preparacion de un pentasacarido.
ES2094848T3 (es) Agente de crecimiento del hepatocito.
FI931740A (fi) Semisyntetiska glukosaminoglykaner innehaollande a-l-galakturonsyra somaer substituerad i 3-staellning med nukleofila radikaler
ITMI912309A1 (it) Oligosaccaridi di dermatan solfato, processo per la loro produzione e relative composizioni farmaceutiche.
ES2062307T3 (es) Un proceso para la fabricacion de glicosaminoglicuronano sulfatado con actividad antitrombotica.
FI941431A0 (fi) Menetelmä puolisynteettisten glykoaminoglykaanien valmistamiseksi, joilla on hepariini- tai heparaanirakenne modifioituna alfa-L-iduroni-2-0-sulfaattihapon 2-asemassa

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960509